Could a psoriasis drug help slow type 1 diabetes?

NCT ID NCT04589325

First seen Apr 30, 2026 · Last updated Apr 30, 2026

Summary

This study tests whether ixekizumab, a drug already approved for psoriasis, can help people newly diagnosed with type 1 diabetes keep making their own insulin for longer. The trial involves 127 adults aged 18-45 who were diagnosed within the last 100 days. Participants receive either the drug or a placebo, and researchers measure insulin production and blood sugar control over 52 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centrum för Diabetes,

    Stockholm, Sweden

  • Falu Lasarett

    Falun, Sweden

  • Karlstad lasarett

    Karlstad, Sweden

  • Kristianstad Hospital

    Kristianstad, Sweden

  • Linköping University Hospital

    Linköping, Sweden

  • Lund University Hospital

    Lund, Sweden

  • Länssjukhuset Ryhov

    Jönköping, Sweden

  • NU-Hospital Group

    Uddevalla, Sweden

  • Sahlgrenska University Hospital, Sahlgrenska

    Gothenburg, Sweden

  • Sahlgrenska University Hospital, Östra Hospital

    Gothenburg, Sweden

  • Skaraborgs sjukhus

    Skövde, Sweden

  • Södersjukhuset Hospital

    Stockholm, Sweden

  • Södra Älvsborg Hospital

    Borås, Sweden

  • Uppsala Academic Hospital

    Uppsala, Sweden

  • Varbergs sjukhus

    Varberg, Sweden

  • Vrinnevi Hospital

    Norrköping, Sweden

  • Örebro University Hospital

    Örebro, Sweden

Conditions

Explore the condition pages connected to this study.